Free Trial
NYSE:AGL

agilon health (AGL) Stock Price, News & Analysis

agilon health logo
$2.76 -0.12 (-4.17%)
As of 01/14/2025 03:58 PM Eastern

About agilon health Stock (NYSE:AGL)

Key Stats

Today's Range
$2.70
$3.05
50-Day Range
$1.58
$2.89
52-Week Range
$1.50
$7.73
Volume
6.03 million shs
Average Volume
4.52 million shs
Market Capitalization
$1.14 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.98
Consensus Rating
Hold

Company Overview

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

agilon health Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
66th Percentile Overall Score

AGL MarketRank™: 

agilon health scored higher than 66% of companies evaluated by MarketBeat, and ranked 399th out of 955 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    agilon health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 14 hold ratings, and 2 sell ratings.

  • Amount of Analyst Coverage

    agilon health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about agilon health's stock forecast and price target.
  • Earnings Growth

    Earnings for agilon health are expected to grow in the coming year, from ($0.52) to ($0.38) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of agilon health is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of agilon health is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    agilon health has a P/B Ratio of 1.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    9.15% of the float of agilon health has been sold short.
  • Short Interest Ratio / Days to Cover

    agilon health has a short interest ratio ("days to cover") of 6.9.
  • Change versus previous month

    Short interest in agilon health has recently decreased by 6.81%, indicating that investor sentiment is improving significantly.
  • Percentage of Shares Shorted

    9.15% of the float of agilon health has been sold short.
  • Short Interest Ratio / Days to Cover

    agilon health has a short interest ratio ("days to cover") of 6.9.
  • Change versus previous month

    Short interest in agilon health has recently decreased by 6.81%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    agilon health has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for agilon health this week, compared to 6 articles on an average week.
  • Search Interest

    6 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added agilon health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, agilon health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $198,100.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of agilon health is held by insiders.

  • Read more about agilon health's insider trading history.
Receive AGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter.

AGL Stock News Headlines

Agilon Health (AGL) was downgraded to a Hold Rating at Stifel Nicolaus
Stunning Trump Exec Order Leaked
Most people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... This could be the most important building in America.
Needham & Company LLC Initiates Coverage on agilon health (NYSE:AGL)
agilon health (NYSE:AGL) Raised to "Neutral" at Citigroup
Agilon Health upgraded to Neutral from Sell at Citi
Agilon Health initiated with a Neutral at Macquarie
See More Headlines

AGL Stock Analysis - Frequently Asked Questions

agilon health's stock was trading at $1.90 at the beginning of 2025. Since then, AGL shares have increased by 45.3% and is now trading at $2.76.
View the best growth stocks for 2025 here
.

agilon health, inc. (NYSE:AGL) posted its quarterly earnings data on Thursday, November, 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.19. The firm earned $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative trailing twelve-month return on equity of 47.84%.

agilon health (AGL) raised $1 billion in an initial public offering (IPO) on Thursday, April 15th 2021. The company issued 46,600,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health's top institutional investors include Pines Wealth Management LLC (0.01%) and Oak Thistle LLC. Insiders that own company stock include Cd&R Investment Associates Ix,, Veeral Desai, John William Wulf, Benjamin Shaker, Steven Sell, Diana Mckenzie, Benjamin Kornitzer, Jeffrey A Schwaneke, Timothy Gertsch and Michael L Smith.
View institutional ownership trends
.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that agilon health investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
11/07/2024
Today
1/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
Healthcare
Fax
N/A
Employees
650
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.98
High Stock Price Target
$9.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+44.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
18 Analysts

Profitability

Net Income
$-262,600,000.00
Pretax Margin
-5.56%

Debt

Sales & Book Value

Annual Sales
$5.59 billion
Book Value
$1.63 per share

Miscellaneous

Free Float
398,833,000
Market Cap
$1.14 billion
Optionable
Not Optionable
Beta
0.53
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NYSE:AGL) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners